Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose hrIL-2 in MTX-Naive Rheumatoid Arthritis
NCT02467504Phase 2Completed
- Sponsor
- Peking University People's Hospital
- Start
- Jul 2015
- Primary completion
- Jan 2017
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of aldesleukin in rheumatoid arthritis (RA), sponsored by Peking University People's Hospital. Started Jul 2015; status: completed.
02
Drugs
aldesleukin
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02467504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02467504.